Derek Le Nguyen

Derek Le Nguyen

Auto-generated profile, based on publicly available information

Derek Le Nguyen

Department of Radiology, Duke University School of Medicine, Durham, NC

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2024 in Radiology
Verified
Journal Article
Closed access
DNDerek L. Nguyen
Derek L. Nguyen
YRYinhao Ren
Yinhao Ren
TJTyler M. Jones
Tyler M. Jones
STSamantha M Thomas
Samantha M Thomas
JLJoseph Lo
Joseph Lo
LGLars J. Grimm
Lars J. Grimm
Patient characteristics influenced the performance of a commercially available artificial intelligence algorithm analyzing true-negative screening digital breast tomosynthesis studies.

25 March 2022 in Academic Radiology
Verified
Journal Article
Closed access
DNDerek L. Nguyen
Derek L. Nguyen
EAEmily B. Ambinder
Emily B. Ambinder
KMKelly S. Myers
Kelly S. Myers
EOEniola Oluyemi
Eniola Oluyemi

19 September 2019 in JAMA Facial Plastic Surgery
Verified
Journal Article
Open access
CWChang Ye Wang
Chang Ye Wang
JDJacob Dudzinski
Jacob Dudzinski
DNDerek Nguyen
Derek Nguyen
EAEric Armbrecht
Eric Armbrecht
IMIan A. Maher
Ian A. Maher
Importance: Smoking, a common lifestyle trait, is considered by many surgeons to be a major risk factor for postoperative complications. However, in the literature on local reconstruction, the association between smoking and the rate of postoperative complications after cutaneous tissue transfer is not well characterized. Objective: To study the outcomes of flaps and grafts used in Mohs micrographic surgery reconstruction with respect to smoking status and patient-specific and surgery-specific variables. Design, Setting, and Participants: This retrospective case-control study was conducted at a single tertiary referral center among 1008 patients who underwent Mohs reconstruction repaired by flap or graft between July 1, 2012, and June 30, 2016, and were selected via consecutive sampling. Cases with incomplete records or those in which a single flap or graft was used to repair multiple defects were excluded. Data analysis was performed from September 2017 to January 2018. Main Outcomes and Measures: Postoperative acute and long-term complications. Acute complications included postsurgical infection, dehiscence, hematoma, uncontrolled bleeding, and tissue necrosis that required medical counseling or intervention. Long-term complications included functional or cosmetic outcomes that prompted the patient to request or the surgeon to offer additional intervention. Results: Of the 1008 patients included in the study (396 women and 612 men), the median (SD) age was 70 (12) years (range, 21-90 years). A total of 128 patients (12.7%) were current smokers, 385 (38.2%) were former smokers, and 495 (49.1%) were never smokers. On multivariate logistic regression, current smoking (odds ratio [OR], 9.58; 95% CI, 3.63-25.3), former smoking (OR, 3.64; 95% CI, 1.41-9.38), larger defect size (OR, 2.25; 95% CI, 1.58-3.20), and the use of free cartilage graft (OR, 8.19; 95% CI, 2.02-33.1) were associated with increased risks of acute complications. For long-term complications, central face location (OR, 25.4; 95% CI, 6.16-106.5), use of interpolation flap or flap-graft combination (OR, 3.49; 95% CI, 1.81-6.74), larger flap size (OR, 1.42; 95% CI, 1.09-1.87), and basal cell carcinomas or other basaloid tumors (OR, 3.43; 95% CI, 1.03-11.5) were associated with an increased risk, whereas increased age (OR, 0.66 per 10-year interval; 95% CI, 0.54-0.80) was associated with decreased risk. Conclusions and Relevance: This study suggests that both current and former smokers are at increased risk for acute postsurgical complications but that smoking status is not associated with long-term complications. These findings may allow the surgeon to better quantify the magnitude of risk and provide helpful information for patient counseling. Level of Evidence: 3 .

28 June 2022 in Journal of Breast Imaging
Verified
Journal Article
Open access
PDF file
DNDerek L Nguyen
Derek L Nguyen
KMKelly S Myers
Kelly S Myers
EOEniola Oluyemi
Eniola Oluyemi
LMLisa A Mullen
Lisa A Mullen
BPBabita Panigrahi
Babita Panigrahi
EAEmily B Ambinder
Emily B Ambinder
Unlike mammography and US, limited data exist to establish well-defined criteria for MRI findings that have a ≤2% likelihood of malignancy. Therefore, determining which findings are appropriate for a BI-RADS 3 assessment on MRI remains challenging and variable among breast radiologists. Emerging data suggest that BI-RADS 3 should be limited to baseline MRI examinations (or examinations with less than two years of prior comparisons) performed for high-risk screening and only used for masses with all of the typical morphological and kinetic features suggestive of a fibroadenoma or dominant enhancing T2 hypointense foci that is distinct from background parenchymal enhancement and without suspicious kinetics. This article presents an updated discussion of BI-RADS 3 assessment (probably benign) for breast MRI using current evidence.

1 March 2024 in Radiology: Imaging Cancer
Verified
Journal Article
Closed access
DNDerek L. Nguyen
Derek L. Nguyen
MLMira Lotfalla
Mira Lotfalla
ACAshley Cimino-Mathews
Ashley Cimino-Mathews
MHMehran Habibi
Mehran Habibi
EAEmily B. Ambinder
Emily B. Ambinder
Purpose To determine the pathologic features of nonmass enhancement (NME) directly adjacent to biopsy-proven malignant masses (index masses) at preoperative MRI and determine imaging characteristics that are associated with a malignant pathologic condition. Materials and Methods This retrospective study involved the review of breast MRI and mammography examinations performed for evaluating disease extent in patients newly diagnosed with breast cancer from July 1, 2016, to September 30, 2019. Inclusion criteria were limited to patients with an index mass and the presence of NME extending directly from the mass margins. Wilcoxon rank sum test, Fisher exact test, and χ2 test were used to analyze cancer, patient, and imaging characteristics associated with the NME diagnosis. Results Fifty-eight patients (mean age, 58 years ± 12 [SD]; all women) were included. Malignant pathologic findings for mass-associated NME occurred in 64% (37 of 58) of patients, 43% (16 of 37) with ductal carcinoma in situ and 57% (21 of 37) with invasive carcinoma. NME was more likely to be malignant when associated with an index cancer that had a low Ki-67 index (<20%) (P = .04). The presence of calcifications at mammography correlating with mass-associated NME was not significantly associated with malignant pathologic conditions (P = .19). The span of suspicious enhancement measured at MRI overestimated the true span of disease at histologic evaluation (P < .001), while there was no evidence of a difference between span of calcifications at mammography and true span of disease at histologic evaluation (P = .27). Conclusion Mass-associated NME at preoperative MRI was malignant in most patients with newly diagnosed breast cancer. The span of suspicious enhancement measured at MRI overestimated the true span of disease found at histologic evaluation. Keywords: Breast, Mammography © RSNA, 2024 See also the commentary by Newell in this issue.

28 September 2022 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
DNDerek L. Nguyen
Derek L. Nguyen
BWBenjamin M. Wilson
Benjamin M. Wilson
EOEniola Oluyemi
Eniola Oluyemi
KMKelly S. Myers
Kelly S. Myers
LMLisa A. Mullen
Lisa A. Mullen
EAEmily B. Ambinder
Emily B. Ambinder